1 Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen
activator inhibitor 1 levels. A possible link between insulin resistance
and atherothrombosis. Diabetologia 1991; 34: 457–62.
2 Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin
Endocrinol Metab 2004; 89: 2548–56.
3 Alessi MC, Peiretti F, Morange P,Henry M, NalboneG, Juhan-Vague
I. Production of plasminogen activator inhibitor 1 by human adipose
tissue: possible link between visceral fat accumulation and vascular
disease. Diabetes 1997; 46: 860–7.
4 Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B,
Nolen GT, Kern EM, Nagarajan R, Spencer HJ III, Lee MJ, Fried
SK,McGehee RE Jr, Peterson CA,Kern PA. Thrombospondin-1 is an
adipokine associated with obesity, adipose inflammation, and insulin
resistance. Diabetes 2008; 57: 432–9.
5 McLaren KM. Immunohistochemical localisation of thrombospondin
in human megakaryocytes and platelets. J Clin Pathol 1983; 36:
197–9.
6 Bornstein P. Thrombospondins as matricellular modulators of cell
function. J Clin Invest 2001; 107: 929–34.
7 Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. The
role of thrombospondin-1 in human disease. J Surg Res 2004; 122:
135–42.
8 Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM,
Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a
major activator of TGF-beta1 in vivo. Cell 1998; 93: 1159–70.
9 Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M,
Geel O, Juhan-Vague I. Plasminogen activator inhibitor 1,
transforming growth factor-b1, and BMI are closely associated in
human adipose tissue during morbid obesity. Diabetes 2000; 49:
1374–80.
10 Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression
of transforming growth factor-beta in adipose tissue from obese
mice. Mol Med 1997; 3: 37–48.
11 Mertens I, Verrijken A, Michiels JJ, Van der Planken M,Ruige JB, van
Gaal LF. Among inflammation and coagulation markers, PAI-1 is a
true component of the metabolic syndrome. Int J Obes (Lond) 2006;
30: 1308–14.
12 O�Hare P. The effects of volume expansion on renal function in insulin
dependent diabetes mellitus. MD thesis, London: Guy’s Hospital,
University of London, 1985.
13 Fried SK, Moustaid-Moussa N. Culture of adipose tissue and isolated
adipocytes. Methods Mol Biol 2001; 155: 197–212.
14 Bayraktar M, Dundar S, Kirazli S, Teletar F. Platelet factor 4, betathromboglobulin
and thrombospondin levels in type I diabetes mellitus
patients. J IntMed Res 1994; 22: 90–4.
15 Tschoepe D, Rauch U, Schwippert B. Platelet-leukocyte-cross-talk in
diabetes mellitus. Horm Metab Res 1997; 29: 631–5.
16 Olson BA, Day JR, Laping NJ. Age-related expression of
renal thrombospondin 1 mRNA in F344 rats: resemblance to
diabetes-induced expression in obese Zucker rats. Pharmacology 1999;
58: 200–8.
17 Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE. Glucose
stimulation of transforming growth factor-beta bioactivity in
mesangial cells is mediated by thrombospondin-1. Am J Pathol 2000;
157: 1353–63.
18 Stegenga ME, van der Crabben SN, LeviM, de Vos AF, Tanck MW,
Sauerwein HP, van der Poll T. Hyperglycemia stimulates coagulation,
whereas hyperinsulinemia impairs fibrinolysis in healthy humans.
Diabetes 2006; 55: 1807–12.
19 Juhan-Vague I, Morange PE, Alessi MC. The insulin resistance syndrome:
implications for thrombosis and cardiovascular disease.
Pathophysiol Haemost Thromb 2002; 32: 269–73.
20 van der Bom JG, Bots ML, Haverkate F, Kluft C, Grobbee DE. The
4G5G polymorphism in the gene for PAI-1 and the circadian
oscillation of plasma PAI-1. Blood 2003; 101: 1841–4.
21 Angleton P, ChandlerWL, Schmer G. Diurnal variation of tissue-type
plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;
79: 101–6.
22 Muller JE, StonePH, Turi ZG,Rutherford JD, Czeisler CA,ParkerC,
Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE,
Willerson JT, Braunwauld E, the MILIS Study Group. Circadian
variation in the frequency of onset of acute myocardial infarction.
N Engl J Med 1985; 313: 1315–22.
23 Marler JR, Price TR, Clark GL, Muller JE, Robertson T, Mohr JP,
Hier DB, Wolf PA, Caplan LR, Foulkes MA. Morning increase in
onset of ischemic stroke. Stroke 1989; 20: 473–6.